Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

DexCom, Inc. (DXCM) Institutional Ownership & Insider Trading

969 institutions reported holding DexCom, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 33 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

DXCMDexCom, Inc.Follow DXCM — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
29.4B
P/E TTM
30.9
Dividend yield
—
52-week
—
Next earnings
10 Feb, in 109 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

969 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +2.7%.

Increased+356New+97Decreased-305Closed-74

Largest moves, shares (millions)

Arrowstreet Capital,…+4.3MCastle Hook Partners+3.1MUBS Group AG+1.7MJPMorgan Chase-2.7MCapital World Investors-1.4MToronto Dominion Bank-1.3M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-21.8Sep 24-8.4Dec 24+3.1Mar 25+0.5Jun 25+8.7Sep 25-10.9Dec 25+7.3Mar 26+10.0Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26969387+2.7%3569730574
Mar 26947363+2.4%34310529072
Dec 25898360-3.0%3269528299
Sep 25885368+2.4%28376297100
Jun 25922363+0.1%2959131376
Mar 25905357+0.9%3407227893
Dec 24916357-2.4%30010930395
Sep 24861352-6.4%29870308181

DexCom, Inc. — questions

Who owns DexCom, Inc. stock?
969 institutions reported DexCom, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (10.1%), VANGUARD CAPITAL MANAGEMENT LLC (6.7%), VANGUARD PORTFOLIO MANAGEMENT LLC (5.2%).
Are DexCom, Inc. insiders buying or selling?
33 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from DexCom, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.